Eli Lilly and Company Common Stock (LLY)

About LLY

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humu…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

50,000

Website

www.lilly.com/

Fundamentals

1-day range

$1,163$1,180

Market cap

$1.06T

P/E (trailing)

43.17

P/E (forward)

24.87

EPS (trailing)

$29.80

Dividend yield

0.75%

Beta

0.45

Avg. volume

2.92M

Ex-dividend date

August 14, 2026

Dividend pay date

September 10, 2026

Forecasts

29 analyst ratings

Eli Lilly and Company Common Stock Competitors

Chosen by industry and closest market cap.

• LLY

  Eli Lilly and Company Common Stock

  $1,174

  ▼ 0.19%
  Market cap $1.06TP/E 43.17
  $712.05$1,293
• JNJ

  Johnson & Johnson Common Stock

  $268.02

  ▲ 0.85%
  Market cap $613.10BP/E 29.93
  $173.33$276.47
• ABBV

  AbbVie Inc. Common Stock

  $255.56

  ▼ 1.01%
  Market cap $433.04BP/E 70.24
  $190.75$267.47
• MRK

  Merck & Company Inc. Common Stock (new)

  $148.32

  ▼ 0.82%
  Market cap $315.57BP/E 103.86
  $77.58$156.92
• NVS

  Novartis AG Common Stock

  $153.79

  ▼ 0.56%
  Market cap $293.23BP/E 21.95
  $96.03$131.5
• AZN

  AstraZeneca PLC Ordinary Shares

  $162.69

  ▼ 1.11%
  Market cap $244.97BP/E 23.44
  $10,784$15,730
• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $208.51BP/E 11.40
  $224.25$409.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk
  SeekingAlpha · 8/22/2026
• Will Eli Lilly’s Global Vault CRM Deal and Leadership Shift Change Veeva Systems’ (VEEV) Narrative?
  Yahoo · 8/22/2026
• Our Top 10 High Growth Dividend Stocks - August 2026
  SeekingAlpha · 8/22/2026
• FFA: Beware Of The AI Risk With This High-Yielding Covered Call Fund
  SeekingAlpha · 8/22/2026
• Eli Lilly (LLY) Is Up 6.4% After UK Clears Foundayo and GLP‑1 Portfolio Advances - What's Changed
  Yahoo · 8/22/2026
• Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
  Yahoo · 8/21/2026
• Eli Lilly Jumps as Weight-Loss Leadership Drives Another Breakout
  Yahoo · 8/21/2026
• Lilly's Multiple Assumes Less Growth Than You Think
  Yahoo · 8/21/2026
• Top 3 Health Care Stocks That Could Blast Off This Month
  benzinga · 8/19/2026

• Donald A. Zakrowski · August 10, 2026 · Sale

  2.0K @ $1,185
• Anat Hakim · August 7, 2026 · Sale

  5.0K @ $1,190
• Melissa Seymour · August 1, 2026 · Option Exercise

  981
• Melissa Seymour · August 1, 2026 · Tax Withholding

  439 @ $1,149
• Juan R. Luciano · July 20, 2026 · Grant

  14 @ $1,147
• J. Erik Fyrwald · July 20, 2026 · Grant

  9 @ $1,147
• Ralph Alvarez · July 20, 2026 · Grant

  11 @ $1,147
• Gabrielle Sulzberger · July 20, 2026 · Grant

  4 @ $1,147
• Juan R. Luciano · June 15, 2026 · Grant

  14 @ $1,129
• J. Erik Fyrwald · June 15, 2026 · Grant

  9 @ $1,129
• Ralph Alvarez · June 15, 2026 · Grant

  11 @ $1,129
• Gabrielle Sulzberger · June 15, 2026 · Grant

  4 @ $1,129
• Ilya Yuffa · June 10, 2026 · Sale

  2.5K @ $1,151
• Juan R. Luciano · May 18, 2026 · Grant

  16 @ $988.09
• J. Erik Fyrwald · May 18, 2026 · Grant

  10 @ $988.09

Institutional Ownership

March 31, 2026

Total shares held

754.24M

Total value held

$667.52B

Institutional holders

4321